Accelero Bioanalytics GmbH is a biotech CRO experienced in the bioanalytics of innovative therapeutics based on nucleic acid or protein/peptide chemistry. Good Laboratory Practice (GLP) services include: sandwich ligand binding assays, Real-Time RT-qPCR, hybridisation, and immunoassays.
Accelero Bioanalytics GmbH supports pharmacokinetic and pharmacodynamic pre-/clinical drug development on microRNA, miRNA, siRNA, aptamers, antisense drugs, as well as peptide hormone or antibody therapeutics.
Innovative, ultrasensitive immunoassay technologies like immuno qPCR or proximity ligation assays allow for peptide/protein quantification in real time.
The company is one of the first to offer GLP compliant bioanalytical Real-Time RT-qPCR.